| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2012-02-07 | Siemens Healthcare Diagnostics (USA), subsidiary of Siemens AG (Germany) Tocagen (USA) | diagnostic tests to support clinical trials related to Tocagen\'s viral gene therapy (Toca 511 & Toca FC) | brain cancer | R&D |
Cancer - Oncology | R&D agreement |
| 2012-02-07 | Prometheus Laboratories (USA - part of Nestlé Health Sciences (Switzerland) - unnamed leading worldwide pharmaceutical company | diagnostic arrays relating to the partner’s oncology pipeline | R&D |
Cancer - Oncology | R&D agreement | |
| 2012-02-06 | Integromics (USA-Spain) Galician Foundation of Genomic Medicine (FPGMX) (Spain) | software solutions for clinical genomics and personalized medicine | R&D |
R&D agreement | ||
| 2012-02-06 | BiolineRx (Israel) Genoscience (France) RFS Pharma (USA) | BL-8030 | hepatitis C | development |
Infectious diseases | Development agreement |
| 2012-02-02 | Alizé Pharma (France) EUSA Pharma, a division of Jazz Pharmaceuticals (Ireland) | Asparec® (L-asparaginase product) | acute lymphoblastic leukemia | licensing |
Cancer - Oncology | Licensing agreement |
| 2012-02-01 | Octoplus (The Netherlands) Ferring Pharmaceuticals (Switzerland) | undisclosed | undisclosed | development |
undisclosed | Development agreement |
| 2012-01-30 | Actavis (Switzerland) Bioton (Poland) | insulins and analogue insulins | diabetes | joint-venture |
Metabolic diseases | Collaboration agreement |
| 2012-01-27 | iNovacia (Sweden) Agios Pharmaceuticals (USA) | small molecule lead generation services | R&D |
Services contract | ||
| 2012-01-26 | Roche (Switerland) Technoclone (Austria) | coagulation assays | R&D co-development |
Cardiovascular diseases - Hematological diseases | ||
| 2012-01-25 | Almirall (Spain) Galapagos (Belgium) | Respiratory diseases | R&D | Respiratory diseases | ||
| 2012-01-24 | Ipsen (France) Santhera Pharmaceuticals (Switzerland) | fipamezole | levodopa-induced dyskinesia in Parkinson's Disease> | licensing (renegociation of an agreement) |
Neurodegenerative diseases - CNS diseases | Licensing agreement |
| 2012-01-24 | Boehringer Ingelheim (Germany) Priaxon (Germany) | mdm2/p53 inhibitors | cancer | R&D |
Cancer - Oncology | R&D agreement |
| 2012-01-24 | BiolineRx (Israel) Genoscience (France) | BL-8020 (ribavirin and hyydroxychloroquine) | hepatitis C | development |
Infectious diseases | Licensing agreement |
| 2012-01-23 | Medigene (Germany) EIP Eczacibasi Ilac Pazarlama A.S. (Turkey) | Veregen® ointment (made from the extract of green tea leaves - catechins) | external genital warts | supply |
Infectious diseases - Gynecology | Commercialisation agreement |
| 2012-01-23 | Sartorius Stedim Biotech (Germany) Refine Technology (USA) | platform for high-density cell cultivation | collaboration |
Development agreement | ||
| 2012-01-20 | Genzyme (USA - MA), a Sanofi company (France) - Veracyte (USA - CA) | Afirma® Thyroid FNA Analysis | thyroid cancer | co-promotion |
Cancer - Oncology | Co-promotion agreement |
| 2012-01-18 | Sartorius Stedim Biotech (Germany) G-Con (USA) | production platforms for the biopharmaceutical manufacturing industry | collaboration |
Production agreement | ||
| 2012-01-18 | Roche (Switzerland) IHU ICAN (France) Inserm Transfert (France) | new molecular targets and new biomarkers | type 2 diabetes | R&D |
Metabolic diseases | R&D agreement |
| 2012-01-17 | Evotec (Germany) Harvard University (USA) | new biomarkers and treatments in the field of kidney disease | kidney diseases | R&D |
Kidney diseases - Renal diseases | R&D agreement |
| 2012-01-17 | Ventana Medical Systems (USA - a member of Roche Group - Switzerland) Bayer (Germany) | molecular companion diagnostic test intended to identify patients most likely to benefit from a novel Bayer antibody-drug conjugate (ADC) | undisclosed | development |
Cancer - Oncology | Development agreement |
